PSP Research LLC

LAS VEGAS, NV · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 21, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$145.8M2026 Q3Cash-like 48.3% · 2026 Q2: 37.5%Weight of Treasury-bill ETFs of a year or less (SGOV, BIL, SHV, USFR, TFLO…) in the book. A 13F shows no cash or money-market funds; this is the closest the filing comes. It is not the fund's actual cash level.
Positions44
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.95.0%

PSP Research LLC reported 44 positions worth $145.8M as of September 30, 2026 (13F filed October 21, 2026). Largest holding: SGOV (48.3%). Biggest move: reduce XBI ($28.9M).

10 / 44 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SGOVIshares Tr$70.5M48.33%700,000——-0.1%
▸ 2 XBISPDR Series$60.9M41.79%386,500——-7.5%
▸ 3 SERASera Prognostics$5.0M3.44%2,396,685——-3.8%
▸ 4 HALOHalozyme Therapeutics$331.2K0.23%3,000——-9.2%
▸ 5 MDGLMadrigal Pharmaceuticals$302.4K0.21%600——-15.9%
▸ 6 EXELExelixis$292.1K0.20%5,000——+14.9%
▸ 7 RPRXRoyalty Pharma$291.8K0.20%5,000——+17.4%
▸ 8 ARGXArgenx$287.7K0.20%300——-0.8%
▸ 9 NRIXNurix Therapeutics$284.5K0.20%12,000——-37.9%
▸ 10 TGTXTG Therapeutics$278.9K0.19%5,000——+15.7%

Pro Feature

The remaining 34 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does PSP Research LLC hold as of Q3 2026?

PSP Research LLC reported 44 positions worth $145.8M in its Q3 2026 13F filing. Largest positions: SGOV (48.3%), XBI (41.8%), SERA (3.4%), HALO (0.2%) and MDGL (0.2%).

What did PSP Research LLC buy in Q3 2026?

New positions: SERA.

What did PSP Research LLC sell in Q3 2026?

Reduced: XBI, HALO, INCY, RPRX and ARGX (27 in all). Sold out entirely: IRON, RAPP, RARE, GLUE and IONS (32 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.